Special Desk With a 79% efficacy against covid, Chinese authorities have given conditional approval for general public use of a vaccine developed by state-owned drug maker Sinopharm. The 79% efficacy rate was claimed in phase three trials. Several Chinese-made vaccines at a late trial stage are already in use after …
Read More »